Literature DB >> 26998599

Patient characteristics for different therapeutic strategies in the management ketamine cystitis.

Jia-Fong Jhang1, Lori A Birder2, Michael B Chancellor3, Hann-Chorng Kuo1.   

Abstract

AIMS: Long-term ketamine abuse results in severely inflamed bladder and intractable bladder pain. Currently there is no guideline for clinician to follow how to manage patients with ketamine cystitis (KC). This study analyzed the KC patient characteristics between who received conservative management and augmentation enterocystoplasty (AE).
METHODS: A total of 53 patients with chronic ketamine abuse and lower urinary tract symptoms were included in this study. All of the patients have been initially treated conservatively but fail. They were admitted for detailed urological examinations. Patients were classified according to their maximal bladder capacity (MBC). The patients with extremely small MBC (<100 ml) with or without upper urinary tract damage and very small MBC with upper urinary tract damage were recommended to receive AE. The patient characteristics and treatment outcome are compared between patients with AE and conservative treatment.
RESULTS: Among them, 28 patients underwent AE and 25 were managed with conservative treatment. The only significant difference between groups was more patients with urgency urinary incontinence underwent AE. Patients underwent AE had significantly smaller MBC, thicker bladder wall, and higher incidence of vesicoureteral reflux. Patients underwent AE reported a good outcome. Most of patients received conservative treatment had a fair result.
CONCLUSIONS: KC patients who already developed a contracted bladder with extremely small bladder capacity (<300 ml) with irreversible urinary tract change, partial cystectomy, and AE seems necessary for early restoration of a normal lower urinary tract function. The treatment outcome of AE is better than patients with conservative treatment. Neurourol. Urodynam. 36:687-691, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  bladder pain; drug abuse; ketamine; pelvic pain; surgery

Mesh:

Substances:

Year:  2016        PMID: 26998599     DOI: 10.1002/nau.22996

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

1.  Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndrome.

Authors:  Chae-Min Ryu; Hwan Yeul Yu; Hye-Yeon Lee; Jung-Hyun Shin; Seungun Lee; Hyein Ju; Bjorn Paulson; Sanghwa Lee; Sujin Kim; Jisun Lim; Jinbeom Heo; Ki-Sung Hong; Hyung-Min Chung; Jun Ki Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Theranostics       Date:  2018-11-09       Impact factor: 11.556

2.  N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model.

Authors:  Chae-Min Ryu; Jung Hyun Shin; Hwan Yeul Yu; Hyein Ju; Sujin Kim; Jisun Lim; Jinbeom Heo; Seungun Lee; Dong-Myung Shin; Myung-Soo Choo
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

3.  The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats.

Authors:  Sang Wook Lee; Chae-Min Ryu; Jung-Hyun Shin; Daeheon Choi; Aram Kim; Hwan Yeul Yu; Ju-Young Han; Hye-Yeon Lee; Jisun Lim; Yong Hwan Kim; Jinbeom Heo; Seungun Lee; Hyein Ju; Sujin Kim; Ki-Sung Hong; Ji-Yeon Han; Miho Song; Hyung-Min Chung; Jun Ki Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Int Neurourol J       Date:  2018-01-31       Impact factor: 2.835

4.  Sexual and bladder dysfunction in male ketamine abusers: A large-scale questionnaire study.

Authors:  Stephen She-Dei Yang; Mei-Yu Jang; Kau-Han Lee; Wen-Tsang Hsu; Yi-Chu Chen; Wan-San Chen; Shang-Jen Chang
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

5.  Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix.

Authors:  Lingjuan Cui; Xiaoyan Jiang; Chengjun Zhang; Danxia Li; Shengqiang Yu; Fengchun Wan; Yue Ma; Wei Guo; Zhengfei Shan
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

6.  Comparison of bladder autoaugmentation by transurethral vesicomyotomy and hydrodistention for ketamine cystitis.

Authors:  Shuo Tan; Xuan Zhu; Zhihuan Zheng; Long Zheng; Ye Kang; Zhengyan Tang
Journal:  Transl Androl Urol       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.